Just with respect to the main addressable markets for Akida, I found it really interesting that in both the recent podcasts Sean seemed to highlight medical over all other applications including automotive, which I thought would be the first one mentioned given the recent Mercedes publicity.
From the Wall Street Journal his answer led with “…the primary verticals that we’re having success in is certainly in medical…”.
So I thought I’d have a look at some medical devices other than Covid testing that might benefit from using Akida.
We know that Akida is great at identifying patterns and is best suited to applications that require low power.
So this put me onto looking at implantable medical devices that rely on low power and long battery life and require good pattern identification skills, which led me to
pacemakers. I think
@Fact Finder has mentioned this before but I don’t recall seeing any articles or research posted.
I stumbled onto an article that has some great comments from Xilinx, Flex Logix and Synapsys regarding the application of AI in medical devices.
We’ve seen some good info on our relationship with Xilinx today. Flex Logix have also been mentioned on the BrainChip website (
https://brainchipinc.com/challenges-of-inferencing-chips/).
But more interestingly is our link with Synapsys which is the company that Rob Teslon has on his CV as being “responsible for building and developing a business focused on disruptive technologies in the semiconductor space”.
Link to the main article here…
https://semiengineering.com/overview-of-medical-chip-challenges/
And extract below.
So what are people’s thoughts on seeing Akida inside something like a pacemaker some time soon? Any chance of joining some dots here?...